https://www.avient.com/resources/safety-data-sheets?page=2782
375CSSVFF PANTONE(R) 375 C SIMULATION 874CSSVFF PANTONE (R) 874 C SIMULATION 160CSSVFF PANTONE(R) 160 C SIMULATION
https://www.avient.com/resources/safety-data-sheets?page=3704
151CPFXHV EPIC PANTONE(R) 151 C SIM 123CPFXHV EPIC PANTONE(R) 123 C SIM 331CPFXHV EPIC PANTONE(R) 331 C SIM
https://www.avient.com/resources/safety-data-sheets?page=6397
16899-10 EXPL9108 NAT 0000 ROYALITE R-55 16899-12 EXPL9110 NAT 0000 ROYALITE R-86 16899-13 EXPL9111 NAT 0000 ROYALITE R-87
https://www.avient.com/resources/safety-data-sheets?page=2007
7427GNSPL PANTONE(R) 7427 C SIMULATION 2925CGNSPL PANTONE(R) 2925 C SIMULATION 1585GNSPL PANTONE(R) 1585 C SIMULATION
https://www.avient.com/resources/safety-data-sheets?page=1979
155CGNS PANTONE(R) 155 C SIMULATION 77777GNS PANTONE(R) GREEN C SIMULATION 3252CGNS PANTONE(R) 3252C SIMULATION
https://www.avient.com/news/polyone-celebrates-opening-new-asia-innovation-center
Activities will include regional and global R&D projects, focusing on high-growth end markets, such as healthcare, packaging, transportation, electronics, and consumer goods. Investor Relations Contact: Eric R.
https://www.avient.com/investor-center/news/avient-hires-dr-vinod-purayath-chief-technology-officer
With nearly 20 years of experience in R&D and scientific leadership, Dr. to drive our R&D strategy into the future," said
https://www.avient.com/investor-center/news/polyone-corporation-investor-day-be-held-conjunction-global-npe-2018-exhibition
Eric R. Investor Relations Contact: Eric R.
https://www.avient.com/investor-center/news/polyone-launches-new-hammerhead-marine-composites
Our investments in R&D and resulting composite portfolio have differentiated Investor Relations Contact: Eric R.
https://www.avient.com/news/alliqua-biomedical-relies-polyone’s-resilience-hc-housings-stand-disinfectants
After extensive material evaluation, the UltraMIST R&D team identified Resilience HC from PolyOne as a potential solution for their new device. We gained speed working with PolyOne,” said Doug Duchon, VP of R&D for Alliqua BioMedical Inc.
